Curative Biosciences, Inc. (CBDX) Financial Statements (2023 and Earlier)

Company Profile

Business Address 5042 WILSHIRE BLVD.
LOS ANGELES, CA 90036
State of Incorp. NV
Fiscal Year End June 30
Industry (SIC) 209 - Miscellaneous Food Preparations And Kindred (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

6/30/2017
6/30/2016
6/30/2015
6/30/2014
6/30/2013
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments  222
Cash and cash equivalents  222
Prepaid expense   2
Other undisclosed current assets    62
Total current assets:  2464
Noncurrent Assets
Property, plant and equipment25811 
Intangible assets, net (including goodwill)  (174)3
Intangible assets, net (excluding goodwill)  (174)3 
Other undisclosed noncurrent assets  174(3)55
Total noncurrent assets:2581155
Other undisclosed assets   1 
TOTAL ASSETS:251016119
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities18835331692105
Accounts payable17716112389105
Accrued liabilities777  
Employee-related liabilities4444 
Taxes payable 18218200
Debt6350   
Estimated litigation liability201201   
Due to related parties  9  
Other undisclosed current liabilities18217381157566
Total current liabilities:633620706249671
Noncurrent Liabilities
Total liabilities:633620706249671
Stockholders' equity
Stockholders' equity attributable to parent, including:(631)(615)(696)(234)(552)
Common stock1616115 
Additional paid in capital52,51652,47950,74547,79217,516
Accumulated deficit(53,162)(53,109)(51,452)(18,085) 
Other undisclosed stockholders' equity attributable to parent   (29,946)(18,067)
Total stockholders' equity:(631)(615)(696)(234)(552)
TOTAL LIABILITIES AND EQUITY:251016119

Income Statement (P&L) ($ in thousands)

6/30/2017
6/30/2016
6/30/2015
6/30/2014
6/30/2013
Revenues   161162
Revenue, net   161 
Cost of revenue    (106)
Gross profit:   16156
Operating expenses(53)(1,657)3,369(29,946)(895)
Other undisclosed operating loss   (161) 
Operating income (loss):(53)(1,657)3,369(29,946)(838)
Income (loss) before gain (loss) on sale of properties:(53)(1,657)3,369(29,946)(838)
Other undisclosed net loss  (6,737)  
Net loss:(53)(1,657)(3,369)(29,946)(838)
Other undisclosed net loss attributable to parent    (5,800)
Net loss available to common stockholders, diluted:(53)(1,657)(3,369)(29,946)(6,638)

Comprehensive Income ($ in thousands)

6/30/2017
6/30/2016
6/30/2015
6/30/2014
6/30/2013
Net loss:(53)(1,657)(3,369)(29,946)(838)
Comprehensive loss, net of tax, attributable to parent:(53)(1,657)(3,369)(29,946)(838)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: